BFLY vs EMBC
BFLY: Butterfly Network is transforming medical imaging with its semiconductor-based, handheld point-of-care ultrasound technology that brings clinical-grade scanning to the palm of the hand. EMBC: A dedicated diabetes care company specializing in insulin delivery systems and pen needles for millions of users worldwide.
Side-by-side fundamentals
| Metric | BFLY | EMBC | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $7.07 | $3.43 | |
| Market cap as of 2026-07-30 | $1.9B | $213M | |
| P/E as of 2026-07-30 | n/a | 1.90 | |
| PEG as of 2026-07-30 | -29.64 | -0.17 | BFLY lower |
| Net margin as of 2026-07-30 | -73.7% | +10.7% | EMBC higher |
| Gross margin as of 2026-07-30 | +49.2% | +61.9% | EMBC higher |
| Operating margin as of 2026-07-30 | -79.5% | +25.8% | EMBC higher |
| ROE as of 2026-07-30 | -36.8% | +6.1% | EMBC higher |
| ROA as of 2026-07-30 | -25.6% | +10.3% | EMBC higher |
| Debt / equity as of 2026-07-30 | 0.00 | 0.00 | Tie |
| Revenue growth (YoY) as of 2026-07-30 | +20.2% | -3.4% | BFLY higher |
| Revenue CAGR (3y) SEC XBRL | +10.0% | -1.5% | BFLY higher |
| Dividend yield as of 2026-07-30 | n/a | +1.1% | |
| Dividend streak (yrs) SEC XBRL | 0 | 4 | EMBC higher |
| Beta as of 2026-07-30 | 2.11 | 0.82 | |
| 1-year return as of 2026-07-27 close | +258.9% | -70.7% | BFLY higher |
Fundamentals: market data, as of 2026-07-30. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.